TransCode Therapeutics, Inc. (RNAZ) — Dilution Risk Analysis
Current Snapshot
TransCode Therapeutics, Inc. (RNAZ) has a DilutionWatch score of 89/10 and is classified as CRITICAL risk. The score date in the source data is 2026-10-03T03:45:52.527348.
This page is assembled from sourced share-structure, market-data, SEC-filing, and DilutionWatch fields. Missing values are left blank rather than estimated.
Dilution Risk Score
Score: 89/10 Source (as of 2026-10-03T03:45:52.527348)
Recent SEC Filings
1 shelf registration or ATM offering filing detected in recent history.
Recent filing forms in the source payload: XBRL 2, S-1 1, S-3 1, 8-K 2.
| Form | Filed | Accession |
|---|---|---|
| xbrl | 2026-06-30 | xbrl-6912-xbrl_convertible |
| S-1 | 2026-05-01 | 0001104659-26-053289 |
| S-3 | 2026-04-30 | 0001104659-26-053187 |
| 8-K | 2026-04-07 | 0001104659-26-040171 |
| 8-K | 2026-03-03 | 0001104659-26-022830 |
| xbrl | 2025-12-31 | xbrl-6912-xbrl_warrant |
Dilution Risk Drivers
| Driver | Stored Value | Source |
|---|---|---|
| Shelf registration capacity | $19,500,000 | Source |
| Cash runway | 6 months | Source |
| Three-year share count growth | 8324.26% | Source |
DilutionWatch Analysis
- Risk Level
- CRITICAL (Score: 89/10) Source
- Cash Runway
- 6 months Source
- Shelf Registration Capacity
- $19,500,000 Source
- Share Count Growth (3-Year)
- 8324.26% Source
What This Page Does Not Estimate
DilutionWatch does not infer missing cash runway, authorized share count, ATM capacity, shelf capacity, or share-growth values on this page. A blank field means the current source payload did not provide a usable value with provenance.
Scores and classifications are shown only when supplied by the DilutionWatch data layer. SEC filing rows link to their source accession when a filing URL is available.